Trials / Unknown
UnknownNCT03949192
Efficacy of Kangliuwan for Recurrent Grade IV Glioma
Efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma: A Prospective Exploratory Clinical Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.
Conditions
Timeline
- Start date
- 2019-06-28
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2019-05-14
- Last updated
- 2020-05-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03949192. Inclusion in this directory is not an endorsement.